Hodgkin Lymphom
Bob-1 is expressed in classic Hodgkin lymphoma
... 24. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Campo E, Montserrat E, ...
5
Prevalence of Hepatitis C virus Genotype 3a in patients with Hodgkin and Non-Hodgkin Lymphoma
... Background and Objectives: Hepatitis C virus (HCV) is a major public health problem worldwide. Replication and per- sistence of HCV genome have been described in the liver tissue as well as B cells lymphocyte. Several ...
6
Hodgkin lymphoma
... Hodgkin lymphoma (HL), a B cell–derived cancer, is one of the most common lymphomas. In HL, the tumor cells — Hodgkin and Reed-Sternberg (HRS) cells — are usually very rare in the tissue. Although HRS cells ...
10
Gastrointestinal non-Hodgkin lymphomas
... Although gastrointestinal (GI) tract is the most common extranodal site involved in non-Hodgkin lymphoma (NHL), primary gastrointestinal NHL (gNHL) is a rare problem which concerns about 10–15% of NHL patients and ...
6
Apoptosis inhibition or inflammation: the role of NAIP protein expression in Hodgkin and non-Hodgkin lymphomas compared to non-neoplastic lymph node
... 39 Hodgkin Lymphoma and 23 Non Hodgkin Lymphoma cases in comparison with 39 control samples (30 normal and 9 Reactive Lymphoid Hyperplasia (RLH) lymph nodes) using semi-quantitative immuno-flourecent ...
9
Understanding Hodgkin Lymphoma
... community health services can provide advice and support. More information on the services is available either from the medical social worker in the hospital before you go home or at your local health centre. Cancer ...
47
Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non Hodgkin and Hodgkin lymphomas
... Figure 2 Promoter CpG methylation of DLEC1 in lymphoma cell lines. A. Diagram shows the DLEC1 CpG island, exon 1 (indicated with a rectangle), and CpG sites (short vertical lines). Numbers from 1 to 61 indicate the ...
7
Fundamentals of the Management of Non Hodgkin Lymphoma
... Fundamentals of the Management of Non Hodgkin Lymphoma Med J Malaysia Vol 64 No 4 December 2009 333 SUMMARY The incidence of Non Hodgkin’s lymphomas (NHL) is rising worldwide and if not adequately tre[.] ...
8
Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters
... HL is one of the most prevalent lymphoproliferative disorders in Pakistan; however, no risk factors for this disease have yet to be established in our population [8]. Although EBV is a well-known risk factor for HL in ...
5
<p>Abdominal Lymphocyte-Depleted Hodgkin Lymphoma: A Rare Presentation</p>
... pleomorphic Hodgkin and Reed-Sternberg cells (HRS) with diffuse polymorphic cellular population in a background of widespread fi ...classical Hodgkin lymphoma Stage II (infradiaphragmatic ...
5
Original Article Classical Hodgkin lymphoma with necrotic granuloma-like morphological features
... Figure 1. The morphologic features of Necrotic Granuloma-like Hodgkin Lymphoma (NGHL). (A) Lymph node biopsy showed scattered multifocal pale staining nodules, a large number of lymphocytes between nodules and was ...
10
Association of HHV-6 with Hodgkin and non Hodgkin lymphoma
... Background and Objectives: Human Herpes 6 virus (HHV-6) could remain latent and chronic in the host cells after pri- mary infection. HHV-6 genome encodes certain transactivation proteins which may results in development ...
6
Demircioglu, Arcan (2004): Vergleich der Polymerase Kettenreaktion und der Southern Blot Analyse beim Nachweis der BCL-2 Translokation bei Patienten mit centroblastisch-centrocytischen und centroblastischen Non-Hodgkin Lymphomen. Dissertation, LMU München: Medizinische Fakultät
... Erstes Ziel der war die Ermittlung der Häufigkeit der bcl-2 Translokation t(14;18) im Bereich der MBR im Knochenmark bei einer Gruppe von Patienten mit centroblastisch- centrocytischen und centroblastischen ...
91
Raffegerst, Silke (2007): Hämatologische Neoplasien in einem transgenen Mausmodell: ein Modell für das Hodgkin-Lymphom?. Dissertation, LMU München: Medizinische Fakultät
... der Hodgkin-ähnlichen Lymphome aus der Maus mit dem humanen ...im Hodgkin-Lymphom, die mittels TZR-Repertoire-Analysen der Vβ-Ketten detektiert wurden und ebenfalls hauptsächlich aus CD4 + -T-Zellen ...
217
Risk Adapted, Combined Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
... German Hodgkin Study Group (GHSG) and European protocols and as intermediate-risk patients in protocols generated in the National Clinical Trials Network (NCTN)/North ...
14
Understanding Hodgkin lymphoma
... Support people affected by cancer Reaching out directly to people with cancer is one of the most rewarding ways to help: ■ Help people needing lifts to hospital by becoming a volunteer d[r] ...
33
Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018
... Early incidence rates for cancer in Lebanon were provided by Abou-Daoud in 1966. Cancer rates were reported at 102.8 and 104.1 per 100,000 for males and females, re- spectively [11]. The study observed high incidence of ...
8
Case report: a unique pediatric case of a primary CD8 expressing ALK-1 positive anaplastic large cell lymphoma of skeletal muscle
... Anaplastic large cell lymphoma (ALCL) was discovered by Stein et al. and characterized by strong expression of the Ki-1 (CD30) antigen [1]. In 1988, ALCL was included in the revised Kiel classification and is nowadays ...
5
Incidence of malignancy in adult patients with rheumatoid arthritis: a meta analysis
... lymphoma, Hodgkin disease, non- Hodgkin lymphoma, lung cancer, colorectal cancer and breast cancer, using data published between 1990 and ...lymphoma, Hodgkin disease, non-Hodgkin lymphoma and ...
10
A REVIEW ON BREAST CANCER
... Women who, as children or young adults, had radiation therapy to the chest area as treatment for another cancer (such as Hodgkin disease or non-Hodgkin lymphoma)[r] ...
17